Michael C. Burger

The paper identifies tertiary lymphoid structures in gliomas as sites of immune response, showing they correlate with better survival and involve T and B cell clonal expansion and plasma cell formation.

This paper engineers AAV9 vectors to selectively deliver genes to specific tumor cell subsets, demonstrating efficacy in preclinical cancer models and clinical relevance.

This paper introduces OncoMimics, a peptide-based immunotherapy using molecular mimicry between commensal bacterial and tumor antigens to induce cross-reactive T cell responses, showing early clinical success in glioblastoma.